Greene Barry E - Aug 5, 2024 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Role
President and CEO, Director
Signature
Brandon Marsh, attorney in fact for GREENE BARRY E.
Stock symbol
SAGE
Transactions as of
Aug 5, 2024
Transactions value $
-$109,966
Form type
4
Date filed
8/7/2024, 04:05 PM
Previous filing
May 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SAGE Common Stock Award $0 +50.4K +107.37% $0.00 97.3K Aug 5, 2024 Direct F1
transaction SAGE Common Stock Tax liability -$110K -12.3K -12.61% $8.96 85.1K Aug 5, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 13, 2024, the reporting person was granted Performance Stock Units (PSUs) to acquire a total of 126,000 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on August 5, 2024, resulting in the vesting of the PSUs as to 50,400 shares.